🇺🇸 FDA
Patent

US 6608197

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

expired A61KA61K31/513A61P

Quick answer

US patent 6608197 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/513, A61P, A61P1/04, A61P13/08